Medical News

RSS

Qureight’s fibrosis imaging biomarker selected by Contineum Therapeutics as a secondary endpoint in Phase 2 PROPEL-IPF clinical trial

Qureight, an end-to-end imaging company providing enterprise-grade imaging and precision endpoints for clinical trials for lung and heart disease, and Contineum Therapeutics, Inc. (Contineum), a clinical-stage biopharmaceutical company pioneering differentiated small molecule therapies for inflammatory and fibrotic diseases with significant unmet need, today announced that Qureight’s Fibr8™ quantitative imaging biomarker is being used as a secondary endpoint in Contineum’s PROPEL-IPF Phase 2 clinical trial examining the safety and efficacy of PIPE-791, Contineum’s lead drug candidate, in idiopathic pulmonary fibrosis (IPF) patients.

10 Nov 2026

European commission approves label expansion of Pepaxti to third-line treatment

Oncopeptides AB (publ), a biotech company focused on difficult-to-treat cancers, today announced that the European Commission (EC) has formally approved the Type II variation application for Pepaxti (melflufen).

From Oncopeptides AB (publ) 10 Nov 2026

Why are some patients lying to their doctors to get antibiotics?

A study finds 28% of adults misrepresent symptoms to secure antibiotics, highlighting risks for antimicrobial resistance and the need for better communication.

10 Nov 2026

Crystal Pharmatech completes ELDICO ED-1 installation; Dedicated MicroED now in routine service

Crystal Pharmatech, a science-driven CRO/CDMO specializing in solid-state research, preformulation studies, and formulation development and manufacturing for small-molecule drugs, today announced that installation of the ELDICO ED-1 electron diffractometer at its Suzhou, China R&D center is complete.

From ELDICO Scientific AG 10 Nov 2026

Your Instagram photos may reveal more about loneliness than you think

Researchers analyzing Instagram data from 415 US college students found that photographs, language, and online activity provided moderately useful indicators of subjective loneliness but were less informative about social isolation. Social loneliness was associated with lower interpersonal engagement, while emotional loneliness was linked to negative language, sad or angry facial expressions in profile photographs, and late-night posting.

9 Nov 2026

Drinking 2–3 cups of coffee a day? A study of 495,000 adults links it to lower AF risk

In a prospective study of 495,269 UK Biobank participants followed for approximately 13 years, researchers found that coffee consumption was associated with a 7% to 11% lower risk of atrial fibrillation (AF), with the strongest association observed at 2–3 cups daily. Tea consumption showed a more modest and less consistent association, with the authors reporting a 5% lower AF risk at 2–3 cups daily, although the observational findings cannot establish causation.

9 Nov 2026

BioUK acquires certain key assets of SEHTA to strengthen support for life science SMEs across the UK

BioUK Ltd., the not-for-profit membership organization focused on catalyzing success in UK life sciences, today announced that it has acquired certain key assets of SEHTA (Science and Engineering Health Technologies Alliance) through an asset purchase agreement.

From BioUK 9 Nov 2026

A child's sex may change how early sugar intake relates to body fat

A longitudinal study of 130 mother-child pairs found that added sugar intake during pregnancy was more strongly associated with body fat in girls, whereas exposure during infancy was more strongly associated with adiposity in boys at age two. The findings, based largely on a smaller group of 42 children with usable body-composition scans, are preliminary and do not establish a causal relationship.

9 Nov 2026

Late night eating and sleep habits damage gut health, increase metabolic disease risk

A new study led by UTHealth Houston identified a link between late-night eating and sleeping habits, gut health, and metabolic disease, offering new insights into why some individuals with obesity may face risk of inflammation and related health problems.

9 Nov 2026

Most eligible teens miss out on advanced obesity treatments

Despite the arrival of powerful new anti-obesity medications and growing evidence supporting weight-loss surgery for adolescents, the vast majority of eligible teens are receiving neither treatment, according to a new study from Ann & Robert H. Lurie Children's Hospital of Chicago published in JAMA Pediatrics.

9 Nov 2026

Complex procedure offers relief for children with chronic pancreatitis

Acute recurrent pancreatitis or chronic pancreatitis can take an enormous toll on children, causing severe pain and repeated hospitalizations.

9 Nov 2026

DNA methylation patterns predict treatment response in MDS patients

DNA methylation patterns present at diagnosis could help predict which patients with myelodysplastic syndromes (MDS) will respond to azacitidine.

9 Nov 2026

UCLA study identifies lipid imbalance as pulmonary fibrosis trigger

A new UCLA Health study in mice has identified a new potential trigger for pulmonary fibrosis: lipid dysregulation (a fat imbalance) within alveolar macrophages.

9 Nov 2026

Rutgers receives grant to explore drug overdose trends among youth

With a $2.9 million grant from the National Institutes of Health, Rutgers researchers will conduct a five-year study exploring trends in drug overdoses in adolescents and young adults.

9 Nov 2026

Study highlights the need for better nutrition tracking in NICUs

During daily rounds in the neonatal intensive care unit (NICU), physicians need to balance many considerations in their decision-making about nutrition plans for premature infants.

9 Nov 2026

Australian-developed MND therapy advances to Phase 2 clinical trial

An Australian-developed therapy aimed at halting motor neurone disease progression and restoring function will advance to a national Phase 2 clinical trial.

9 Nov 2026

Minor sleep loss increases risk of phishing scam traps

Nearly a third of adults in the U.S. do not get enough sleep. A recent surge in attention to this issue raises serious concerns about its long-term health implications, and new research suggests that it can lead to hazardous outcomes, especially in the context of "phishing" emails.

9 Nov 2026

Animal study raises questions about semaglutide safety during pregnancy

They're the blockbuster drugs transforming weight loss, helping millions of people to shed unwanted kilos.

9 Nov 2026

New treatment approach could help people with muscle-invasive bladder cancer live longer

A new treatment approach could help people with an aggressive form of bladder cancer live longer and reduce the chances of their cancer returning or progressing, particularly those who cannot receive standard chemotherapy, according to findings from a large international clinical trial co-led by researchers at the UCLA Health Jonsson Comprehensive Cancer Center.

9 Nov 2026

Survey shows Americans miss key everyday fall risk factors

A fear of falling may cause people to avoid stairs, exercise and other daily activities. But that fear can also increase the risk of a fall.

9 Nov 2026

1
2
3
4
...
18311
Next

Medical News

Qureight’s fibrosis imaging biomarker selected by Contineum Therapeutics as a secondary endpoint in Phase 2 PROPEL-IPF clinical trial

European commission approves label expansion of Pepaxti to third-line treatment

Why are some patients lying to their doctors to get antibiotics?

Crystal Pharmatech completes ELDICO ED-1 installation; Dedicated MicroED now in routine service

Your Instagram photos may reveal more about loneliness than you think

Drinking 2–3 cups of coffee a day? A study of 495,000 adults links it to lower AF risk

BioUK acquires certain key assets of SEHTA to strengthen support for life science SMEs across the UK

A child's sex may change how early sugar intake relates to body fat

Late night eating and sleep habits damage gut health, increase metabolic disease risk

Most eligible teens miss out on advanced obesity treatments

Complex procedure offers relief for children with chronic pancreatitis

DNA methylation patterns predict treatment response in MDS patients

UCLA study identifies lipid imbalance as pulmonary fibrosis trigger

Rutgers receives grant to explore drug overdose trends among youth

Study highlights the need for better nutrition tracking in NICUs

Australian-developed MND therapy advances to Phase 2 clinical trial

Minor sleep loss increases risk of phishing scam traps

Animal study raises questions about semaglutide safety during pregnancy

New treatment approach could help people with muscle-invasive bladder cancer live longer

Survey shows Americans miss key everyday fall risk factors

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

Latest News